A new report has been launched, which highlights the critical importance of the Medical Technologies (MedTech) sector to the Midlands economy.
The report focuses upon the nature and scale of the MedTech sector, its contribution to the regional economy, what Midlands businesses need to achieve growth, and barriers faced.
Hatch Regeneris has undertaken an assessment of the nature and scale of the Midlands MedTech, its contribution to the regional economy, what MedTech businesses in the Midlands need to achieve growth and increased productivity, and the barriers they face in achieving this.
It is fantastic to see the Midlands well represented in successful stage 1 Strength in Places Fund awards. Industry driven Research and Innovation for patient benefit and productivity uplift is core to these programmes. MHI and its partners fully support these initiatives.
The government’s new Life Sciences Sector Deal, published today (5th Dec 2018), highlights the significant role that the Midlands plays in the UK’s Life Sciences sector.
On 1st October, partners from across the Midlands region welcomed Professor Sir John Bell to explore the considerable Life Science strengths and opportunities present.
The Midlands region has been propelled to the forefront of the UK’s NMR capability, thanks to a £20m investment across UK institutions from the EPSRC.
Health Data Research UK is awarding £30 million funding to six sites across the UK to address challenging healthcare issues through use of data science. Each site has world-class expertise; a track record in using health data to derive new knowledge, scientific discovery and insight; and works in close partnership with NHS bodies and the public to translate research findings into benefits for patients and populations.